Inventor · disambiguated record
Bishwajit Nag
Also filed as: NAG BISHWAJIT
40 granted patents·14 pending applications·618 citations·filing 1990–2024
98Inventor score
Files withBEXEL PHARMACEUTICALS INC11CALYX THERAPEUTICS INC10RENOVEL INNOVATIONS INC10ANERGEN INC8THERACOS INC7
Top patents by PatentIndex Score
54 records- 0191US11807619B2Para acyl substituted diazacyclohexene derivativesRENOVEL INNOVATIONS INC·Filed 2021·Granted Nov 7, 2023·2 cites·7 claims
- 0291US6624197B1Diphenylethylene compoundsCALYX THERAPEUTICS INC·Filed 2000·Granted Sep 23, 2003·36 cites·18 claims
- 0390US5734023AMHC class II β chain/peptide complexes useful in ameliorating deleterious immune responsesANERGEN INC·Filed 1995·Granted Mar 31, 1998·106 cites·7 claims
- 0487US5763585AMethod of making MHC-peptide complexes using metal chelate affinity chromatographyANERGEN INC·Filed 1994·Granted Jun 9, 1998·54 cites·11 claims
- 0587US5334391AIntracellularly cleavable compoundsANERGEN INC·Filed 1992·Granted Aug 2, 1994·45 cites·3 claims
- 0686US11760743B2Acyloxy substituted phenyl dithiane derivativesRENOVEL INNOVATIONS INC·Filed 2021·Granted Sep 19, 2023·1 cites·7 claims
- 0785US7521465B2Diphenyl ether derivativesBEXEL PHARMACEUTICALS INC·Filed 2005·Granted Apr 21, 2009·14 cites·24 claims
- 0885US6245814B1Diphenylethylene compoundsCALYX THERAPEUTICS INC·Filed 1998·Granted Jun 12, 2001·35 cites·2 claims
- 0984US7087576B2Dipeptide phenyl ethersBEXEL PHARMACEUTICALS INC·Filed 2003·Granted Aug 8, 2006·12 cites·23 claims
- 1083US12195441B2Para acyl substituted diazacyclohexene derivativesRENOVEL INNOVATIONS INC·Filed 2023·Granted Jan 14, 2025·0 cites·21 claims
- 1183US6794401B2Amino acid phenoxy ethersBEXEL PHARMACEUTICALS INC·Filed 2003·Granted Sep 21, 2004·19 cites·39 claims
- 1283US5854285AProtein kinase inhibitorNATPRO INC·Filed 1997·Granted Dec 29, 1998·26 cites·7 claims
- 1383US2025136572A1Para acyl substituted diazacyclohexene derivativesRENOVEL INNOVATIONS INC·Filed 2024·Application pending·0 cites
- 1481US2024300883A1Styryl carboxylate derivativesRENOVEL INNOVATIONS INC·Filed 2024·Application pending·0 cites
- 1581US2024317670A1Styryl carboxylate derivativesRENOVEL INNOVATIONS INC·Filed 2024·Application pending·0 cites
- 1680US12227487B1Acyloxy substituted phenyl dithiane derivativesRENOVEL INNOVATIONS INC·Filed 2023·Granted Feb 18, 2025·0 cites·3 claims
- 1779US7781464B2Heterocyclic diphenyl ethersBEXEL PHARMACEUTICALS INC·Filed 2006·Granted Aug 24, 2010·7 cites·11 claims
- 1879US2025129015A1Halogenated benzylidine derivativesRENOVEL INNOVATIONS INC·Filed 2024·Application pending·0 cites
- 1977US7105552B2Heterocyclic analogs of diphenylethylene compoundsTHERACOS INC·Filed 2001·Granted Sep 12, 2006·10 cites·108 claims
- 2077US6194453B1Protein kinase inhibitorCALYX THERAPEUTICS INC·Filed 1998·Granted Feb 27, 2001·14 cites·6 claims
- 2176US7521466B2Dipeptide phenyl ethersBEXEL PHARMACEUTICALS INC·Filed 2006·Granted Apr 21, 2009·2 cites·17 claims
- 2275US7399786B2Derivatives of amino acids for treatment of obesity and related disordersBEXEL PHARMACEUTICALS INC·Filed 2005·Granted Jul 15, 2008·5 cites·24 claims
- 2374US12195418B2Halogenated benzylidene derivativesRENOVEL INNOVATIONS INC·Filed 2022·Granted Jan 14, 2025·0 cites·5 claims
- 2474US11987551B2Styryl carboxylate derivativesRENOVEL INNOVATIONS INC·Filed 2021·Granted May 21, 2024·0 cites·16 claims
- 2574US7456292B2Hydroxamic acid-containing amino acid derivativesBEXEL PHARMACEUTICALS INC·Filed 2005·Granted Nov 25, 2008·4 cites·16 claims
- 2674US6852695B2Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetesTHERACOS INC·Filed 2002·Granted Feb 8, 2005·3 cites·29 claims
- 2774US6555702B2Protein kinase inhibitorCALYX THERAPEUTICS INC·Filed 1998·Granted Apr 29, 2003·11 cites·10 claims
- 2873US6331633B1Heterocyclic analogs of diphenylethylene compoundsCALYX THERAPEUTICS INC·Filed 1999·Granted Dec 18, 2001·35 cites·8 claims
- 2972US6855732B2Compounds to treat diabetes and associated conditionsTHERACOS INC·Filed 2002·Granted Feb 15, 2005·6 cites·6 claims
- 3072US5595881AMethod for the detection of antigen presenting cellsANERGEN INC·Filed 1994·Granted Jan 21, 1997·44 cites·7 claims
- 3167US5169934AIntracellularly cleavable compoundsANERGEN INC·Filed 1990·Granted Dec 8, 1992·20 cites·1 claims
- 3265US7202366B2Heterocyclic analogs of diphenylethylene compoundsTHERACOS INC·Filed 2004·Granted Apr 10, 2007·2 cites·12 claims
- 3365US6090587AProkaryotic expression of MHC proteinsCORIXA CORP·Filed 1995·Granted Jul 18, 2000·21 cites·8 claims
- 3463US6391854B1Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetesCALYX THERAPEUTICS INC·Filed 2000·Granted May 21, 2002·1 cites·17 claims
- 3561US6045796AVaccination with peptide of MHC class II molecules for treatment of autoimmune diseaseANERGEN INC·Filed 1995·Granted Apr 4, 2000·17 cites·35 claims
- 3659US7407978B2Heterocyclic analogs of diphenylethylene compoundsTHERACOS INC·Filed 2002·Granted Aug 5, 2008·1 cites·6 claims
- 3757US6413504B1Alpha-arylated cinnamic esters and 1,4-bis(alpha-carboxyl-beta-styryl)benzene esters an UV-blocking agentsCALYX THERAPEUTICS INC·Filed 2000·Granted Jul 2, 2002·2 cites·14 claims
- 3857US6127338AOrally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetesCALYX THERAPEUTICS INC·Filed 1998·Granted Oct 3, 2000·13 cites·5 claims
- 3956US6448450B11-(3,5-dimethoxyphenyl)-2-(4-hydroxyphenyl)-ethylene for diabetes treatmentCALYX THERAPEUTICS INC·Filed 1998·Granted Sep 10, 2002·23 cites·1 claims
- 4055US6007820APurification and characterization of MHC-peptide complexes useful in ameliorating autoimmunityANERGEN INC·Filed 1995·Granted Dec 28, 1999·7 cites·14 claims
- 4155US5824315ABinding affinity of antigenic peptides for MHC moleculesANERGEN INC·Filed 1996·Granted Oct 20, 1998·14 cites·32 claims
- 4253US2006235062A1Novel heterocyclic analogs of diphenylethylene compoundsTHERACOS INC·Filed 2003·Application pending·0 cites
- 4352US2005096366A1Amino acid phenoxy ethersBEXEL PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 4450US2008261981A1Novel derivatives of amino acids for treatment of obesity and related disordersBEXEL PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 4548US2004180063A1Vaccination with peptide of MHC class ll molecules for treatment of autoimmune diseaseFiled 2002·Application pending·0 cites
- 4646US6525093B1Compounds to treat diabetes and associated conditionsCALYX THERAPEUTICS INC·Filed 1999·Granted Feb 25, 2003·6 cites·56 claims
- 4743US2008200521A1Novel hydroxamic acid containing amino acid derivativesBEXEL PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 4841US2008175795A1Novel derivatives of amino acids for treatment of obesity and related disordersBEXEL PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 4939US6723736B2Tricyclic compounds and uses thereofTHERACOS INC·Filed 2001·Granted Apr 20, 2004·0 cites·43 claims
- 5038US2008319031A1Novel Tyrosine DerivativesORCHID CHEMICALS & PHARM LTD·Filed 2006·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Bishwajit Nag files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →